RARA CRAFT DATABASE for FDA Medical Devices
510(k)K191084

FDA DEVICE FACTS

The Optimotion Blue Total Knee System

Optimotion Implants, LLC

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 7, 2020PRODUCT CODEMBH

Indications for use

« Painful, disabling joint disease of the knee resulting from; noninflammatory degenerative joint disease (including osteoarthritis, traumatic arthritis, or avascular necrosis), rheumatoid arthritis or post-traumatic arthritis.

¢ Post-traumatic loss of knee joint configurations and function.

¢ Moderate varus, valgus, or flexion deformity in which the ligamentous structures can be returned to adequate function and stability.

¢ Revision of previous unsuccessful knee replacement or other procedure.

¢ Fracture of the distal femur and/or proximal tibia that cannot be stabilized by standard fracture-management techniques.

Optimotion™ Blue Porous Tibial Baseplate components are indicated for Cemented or Cementless use. The Optimotion™ Blue Porous CR Femoral components are indicated for Cemented or Cementless use. The Optimotion™ Blue CEMENTED CR Femoral and CEMENTED Tibial Baseplate components are indicated for cemented use only.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026